They reported losing 35 pounds overall but struggled with side effects at higher doses, including food aversion and an extremely sensitive gag reflex
What to expect during the transition Every medication switch comes with an adjustment period
It reflects the biology: obesity is a chronic condition involving reset appetite set points, altered hormonal signaling, and metabolic adaptation
References Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is widely used for the management of type 2 diabetes mellitus (T2DM) due to its efficacy in improving glycemic control and reducing cardiovascular risk
6 This data brief examines trends in the prescription of five GLP-1 drugs for weight loss, compares total costs between Medi-Cal and commercial payers for each drug, and maps the average total yearly cost (paid cost + out-of-pocket cost) per member by county
This product is intended exclusively for in-vitro laboratory and research purposes